课题基金 / 基金详情

Development of gene therapy for oral cancer mediated by Naked DNA of molecule processing E-cadherin

Development of gene therapy for oral cancer mediated by Naked DNA of molecule processing E-cadherin
分子加工E-钙粘蛋白的裸DNA介导的口腔癌基因治疗的进展
批准号:
24792218
负责人:
HAMANA Tomoaki
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study showed that oral cancer cells transferred gene of alpha2-antiplasmin (alpha2-AP) which is plasmin inhibitor were remarkably suppressed in vivo tumor formation and expression of E-cadherin increased in the formed tumor. The results suggest that inducing of alpha2-AP protein suppresses tumor invasion and metastasis by increasing not only proteolytic activity but also cell migration and proliferation. Therefor, it is expected the development of novel gene therapy by inducing of alpha2-AP for oral cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金